-+ 0.00%
-+ 0.00%
-+ 0.00%

Yuandong Biotech announced that Tibet Runhe Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received a “Tax Handling Decision” from the tax authorities. Since it obtained non-compliant invoices from upstream service providers in 2017-2021, it was necessary to pay 4.491,000 yuan in corporate income tax and add late fees, which did not involve administrative penalties. As of the date of disclosure of the announcement, Tibet Runhe had paid a total of 9.6838 million yuan in taxes and late fees. The matter has been closed. Tibet Runhe has already calculated the full amount of relevant supplementary taxes, late fees, and fines in 2025. In 2026, some of the taxes, late fees and fines originally calculated will be reversed. This incident will not affect the normal operation of the company.

Zhitongcaijing·11/17/2026 09:25:09
Listen to the news
Yuandong Biotech announced that Tibet Runhe Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received a “Tax Handling Decision” from the tax authorities. Since it obtained non-compliant invoices from upstream service providers in 2017-2021, it was necessary to pay 4.491,000 yuan in corporate income tax and add late fees, which did not involve administrative penalties. As of the date of disclosure of the announcement, Tibet Runhe had paid a total of 9.6838 million yuan in taxes and late fees. The matter has been closed. Tibet Runhe has already calculated the full amount of relevant supplementary taxes, late fees, and fines in 2025. In 2026, some of the taxes, late fees and fines originally calculated will be reversed. This incident will not affect the normal operation of the company.